Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.

Digestive diseases and sciences - 1 Nov 1994

Diodati G, Bonetti P, Tagger A, Casarin C, Noventa F, Ribero M, Fasola M, Ruol A, Realdi G

Abstract excerpt

Hepatitis C virus is the most frequent cause of chronic non-A, non-B hepatitis, and the antibodies to structural and nonstructural proteins encoded by viral genome have been suggested to be markers of ongoing HCV infection. We studied the behavior of these antibodies during interferon therapy in 18 patients with chronic hepatitis C and also during a follow-up period of at least four years. A significant decrease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C

Share to Polymerase Chain Reaction

Share to Recombinant Proteins

Share to RNA, Viral

Source

Identifiers

PMID: 7525169
DOI: 10.1007/BF02087672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.PMID 7525169Read ↗

[Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].Semantic proximity Read ↗

Molecular, genetic, and morphological markers during persistence of RNA-containing hepatitis C virus in the body.Semantic proximity Read ↗

The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C virusesSemantic proximity Read ↗

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan.Semantic proximity Read ↗

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses.Semantic proximity Read ↗

Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.Semantic proximity Read ↗

Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype.Semantic proximity Read ↗

Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C.Semantic proximity Read ↗

Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.Semantic proximity Read ↗

Prompt decrease of circulating hepatitis C virus in patients with chronic hepatitis C after treatment with interferon.Semantic proximity Read ↗

Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon.Semantic proximity Read ↗

Long-term persistence of anti-rods and rings antibodies in patients with chronic hepatitis C after antiviral treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.